A detailed history of Banque Cantonale Vaudoise transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 2,159 shares of CRL stock, worth $402,977. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,159
Previous 2,232 3.27%
Holding current value
$402,977
Previous $461,000 7.81%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$187.96 - $245.29 $13,721 - $17,906
-73 Reduced 3.27%
2,159 $425,000
Q2 2024

Jul 31, 2024

BUY
$206.39 - $268.73 $44,373 - $57,776
215 Added 10.66%
2,232 $461,000
Q1 2024

Apr 10, 2024

BUY
$203.52 - $273.43 $25,643 - $34,452
126 Added 6.66%
2,017 $547,000
Q4 2023

Feb 07, 2024

SELL
$164.52 - $238.84 $134,906 - $195,848
-820 Reduced 30.25%
1,891 $447,000
Q3 2023

Nov 08, 2023

SELL
$194.44 - $217.61 $8,555 - $9,574
-44 Reduced 1.6%
2,711 $532,000
Q2 2023

Aug 09, 2023

BUY
$183.71 - $210.25 $35,088 - $40,157
191 Added 7.45%
2,755 $579,000
Q1 2023

Apr 20, 2023

SELL
$191.89 - $259.92 $5,181 - $7,017
-27 Reduced 1.04%
2,564 $517,000
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $7,095 - $9,002
36 Added 1.41%
2,591 $565,000
Q3 2022

Oct 17, 2022

SELL
$182.44 - $250.54 $5,655 - $7,766
-31 Reduced 1.2%
2,555 $502,000
Q2 2022

Aug 02, 2022

SELL
$204.13 - $302.4 $8,369 - $12,398
-41 Reduced 1.56%
2,586 $553,000
Q1 2022

May 09, 2022

SELL
$255.51 - $362.11 $578,219 - $819,454
-2,263 Reduced 46.28%
2,627 $746,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $133,524 - $170,498
-380 Reduced 7.21%
4,890 $1.84 Million
Q3 2021

Oct 29, 2021

BUY
$372.64 - $458.3 $90,924 - $111,825
244 Added 4.85%
5,270 $2.18 Million
Q2 2021

Aug 11, 2021

BUY
$294.17 - $371.65 $667,177 - $842,902
2,268 Added 82.23%
5,026 $1.86 Million
Q1 2021

May 11, 2021

SELL
$249.67 - $299.48 $141,313 - $169,505
-566 Reduced 17.03%
2,758 $799,000
Q4 2020

Feb 05, 2021

BUY
$222.0 - $252.62 $96,126 - $109,384
433 Added 14.98%
3,324 $831,000
Q3 2020

Oct 30, 2020

BUY
$175.56 - $226.45 $6,144 - $7,925
35 Added 1.23%
2,891 $654,000
Q2 2020

Jul 22, 2020

BUY
$118.84 - $189.72 $32,681 - $52,173
275 Added 10.65%
2,856 $498,000
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $24,725 - $44,585
-250 Reduced 8.83%
2,581 $326,000
Q4 2019

Feb 10, 2020

BUY
$126.05 - $152.76 $356,847 - $432,463
2,831 New
2,831 $432,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.